MaxCyte, Inc. (LON:MXCT – Get Free Report)’s share price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 346 ($4.35) and traded as low as GBX 264 ($3.32). MaxCyte shares last traded at GBX 264 ($3.32), with a volume of 29,582 shares traded.
MaxCyte Price Performance
The company has a debt-to-equity ratio of 8.59, a quick ratio of 14.38 and a current ratio of 9.81. The company has a market capitalization of £348.49 million, a PE ratio of -9.67 and a beta of 1.13. The company’s 50-day simple moving average is GBX 344.76 and its 200-day simple moving average is GBX 313.89.
MaxCyte Company Profile
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients.
Featured Stories
- Five stocks we like better than MaxCyte
- What is the Nasdaq? Complete Overview with History
- Chaos and Cash: Finding Opportunity in Volatility
- What is the S&P/TSX Index?
- Realty Income: An Anchor in Volatile Markets
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
